Lisinopril HCTZ

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-21-R-0112

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
The Defense Logistics Agency (DLA) Troop Support, a federal office, has issued a national contract solicitation under procurement identifier SPE2D2-21-R-0112 for the supply of Lisinopril HCTZ. This solicitation seeks qualified contractors capable of manufacturing and delivering pharmaceutical preparations, specifically Lisinopril HCTZ, in accordance with the requirements outlined by the agency. The procurement falls under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on drugs and biologicals. The primary objective of this procurement is to establish a reliable supply chain for Lisinopril HCTZ, ensuring that the agency’s needs for this essential medication are met efficiently and in compliance with federal standards. Contractors are expected to provide products that adhere to stringent quality and regulatory requirements, supporting the health and readiness of the populations served by DLA Troop Support. Interested parties should note that the solicitation is currently active, with all relevant details and attachments available through the official SAM.gov opportunity listing (Opportunity ID: cb62c20444494c6997cf8199df7adef5). The notice includes three attachments, which likely contain critical information regarding technical specifications, submission instructions, and contractual terms. Prospective offerors are encouraged to review these documents thoroughly to ensure full compliance with solicitation requirements. The contracting activity is managed by DLA Troop Support, with primary and secondary points of contact provided for inquiries: Ryan Ferry ([email protected], 215-737-3182) and Jason Wray ([email protected], 215-737-0614). These contacts can address questions related to the solicitation process, technical requirements, and administrative procedures. While the notice does not specify set-aside requirements or special considerations, contractors should be prepared to demonstrate their capability to meet federal procurement standards for pharmaceutical products. The scope of work and deliverables are expected to remain consistent throughout the contract lifecycle, focusing on the reliable manufacture and supply of Lisinopril HCTZ. This opportunity is well-suited for contractors with established expertise in pharmaceutical preparation manufacturing, robust quality assurance processes, and experience in federal contracting. Interested vendors should access the full solicitation and attachments via the provided SAM.gov link to evaluate alignment with their capabilities and prepare a responsive proposal.